N	Concordance
1	en is used concomitantly. Clonidine and medroxyprogesterone may constitute poten
2	          Progestational agents such as medroxyprogesterone or megestrol acetate
3	nificantly associated with use of depot medroxyprogesterone acetate (odds ratio 
4	 different oral progestogens (10 mg/day medroxyprogesterone acetate [MPA] in the
5	3) M L-histidine enhanced the effect of medroxyprogesterone acetate in reducing 
6	ate the effectiveness of high-dose oral medroxyprogesterone acetate therapy in t
7	molgus monkeys the synthetic progestin, medroxyprogesterone acetate (MPA), decre
8	esent for the first few weeks of taking Medroxyprogesterone acetate, but often t
9	 incubating cultured stromal cells with medroxyprogesterone acetate (MPA) and oe
10	 (spotting) while having treatment with Medroxyprogesterone acetate. This is not